Intuitive Surgical, Inc.

NasdaqGS:ISRG Stock Report

Mkt Cap: US$109.4b

We’ve recently updated our valuation analysis.

Intuitive Surgical Valuation

Is ISRG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ISRG?

Other financial metrics that can be useful for relative valuation.

ISRG key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue16.3x
Enterprise Value/EBITDA53.8x
PEG Ratio4.9x

Price to Earnings Ratio vs Peers

How does ISRG's PE Ratio compare to its peers?

The above table shows the PE ratio for ISRG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average47.3x
SYK Stryker
40.2x12.4%US$105.6b
MDT Medtronic
29.7x11.9%US$111.5b
BSX Boston Scientific
88.1x23.3%US$74.5b
ABT Abbott Laboratories
31.4x7.8%US$181.2b
ISRG Intuitive Surgical
83.4x16.4%US$109.4b

Price-To-Earnings vs Peers: ISRG is expensive based on its Price-To-Earnings Ratio (83.4x) compared to the peer average (47.3x).

Price to Earnings Ratio vs Industry

How does ISRG's PE Ratio compare vs other companies in the US Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a18.7%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a18.7%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: ISRG is expensive based on its Price-To-Earnings Ratio (83.4x) compared to the US Medical Equipment industry average (36.4x)

Price to Earnings Ratio vs Fair Ratio

What is ISRG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ISRG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio83.4x
Fair PE Ratio43.5x

Price-To-Earnings vs Fair Ratio: ISRG is expensive based on its Price-To-Earnings Ratio (83.4x) compared to the estimated Fair Price-To-Earnings Ratio (43.5x).

Share Price vs Fair Value

What is the Fair Price of ISRG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ISRG ($312.18) is trading above our estimate of fair value ($170.73)

Significantly Below Fair Value: ISRG is trading above our estimate of fair value.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ISRG forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$312.18
US$308.19
-1.3%
10.1%US$365.00US$204.00n/a21
May ’24US$303.02
US$305.24
+0.7%
9.6%US$350.00US$204.00n/a21
Apr ’24US$255.47
US$271.48
+6.3%
11.5%US$325.00US$204.00n/a21
Mar ’24US$227.33
US$273.80
+20.4%
12.3%US$325.00US$204.00n/a20
Feb ’24US$251.19
US$273.80
+9.0%
12.3%US$325.00US$204.00n/a20
Jan ’24US$265.35
US$271.05
+2.1%
14.7%US$325.00US$204.00n/a21
Dec ’23US$274.49
US$260.30
-5.2%
13.8%US$325.00US$204.00n/a20
Nov ’23US$246.86
US$252.30
+2.2%
12.4%US$325.00US$204.00n/a20
Oct ’23US$187.44
US$252.18
+34.5%
14.7%US$325.00US$175.00n/a17
Sep ’23US$206.11
US$251.59
+22.1%
14.7%US$325.00US$175.00n/a17
Aug ’23US$228.54
US$251.29
+10.0%
14.7%US$325.00US$175.00n/a17
Jul ’23US$206.10
US$313.58
+52.1%
14.9%US$395.00US$204.00n/a19
Jun ’23US$216.39
US$317.79
+46.9%
13.3%US$395.00US$204.00US$310.5419
May ’23US$239.30
US$325.05
+35.8%
13.8%US$395.00US$182.00US$303.0219
Apr ’23US$305.54
US$327.35
+7.1%
14.1%US$395.00US$182.00US$255.4717
Mar ’23US$291.55
US$326.56
+12.0%
14.5%US$395.00US$182.00US$227.3316
Feb ’23US$286.51
US$328.00
+14.5%
16.0%US$425.00US$182.00US$251.1916
Jan ’23US$359.30
US$351.14
-2.3%
15.5%US$425.00US$182.00US$265.3514
Dec ’22US$319.93
US$349.00
+9.1%
14.9%US$398.00US$182.00US$274.4914
Nov ’22US$355.03
US$343.02
-3.4%
14.9%US$395.00US$175.00US$246.8616
Oct ’22US$336.50
US$333.37
-0.9%
14.5%US$393.33US$175.00US$187.4417
Sep ’22US$354.24
US$330.25
-6.8%
14.5%US$393.33US$175.00US$206.1116
Aug ’22US$330.49
US$327.85
-0.8%
14.2%US$377.67US$175.00US$228.5416
Jul ’22US$309.15
US$289.00
-6.5%
11.9%US$320.00US$166.67US$206.1016
Jun ’22US$278.68
US$288.50
+3.5%
11.9%US$320.00US$166.67US$216.3916

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies